Literature DB >> 23990208

Hepatic cholesterol homeostasis: is the low-density lipoprotein pathway a regulatory or a shunt pathway?

Allan D Sniderman1, Yanqin Qi, Cheng-I J Ma, Rui Hao Leo Wang, Mark Naples, Chris Baker, Jing Zhang, Khosrow Adeli, Robert S Kiss.   

Abstract

OBJECTIVE: The hypothesis that cholesterol that enters the cell within low-density lipoprotein (LDL) particles rapidly equilibrates with the regulatory pool of intracellular cholesterol and maintains cholesterol homeostasis by reducing cholesterol and LDL receptor synthesis was validated in the fibroblast but not in the hepatocyte. Accordingly, the present studies were designed to compare the effects of cholesterol that enters the hepatocyte within an LDL particle with those of cholesterol that enters via other lipoprotein particles. APPROACH AND
RESULTS: We measured cholesterol synthesis and esterification in hamster hepatocytes treated with LDL and other lipoprotein particles, including chylomicron remnants and VLDL. Endogenous cholesterol synthesis was not significantly reduced by uptake of LDL, but cholesterol esterification (280%) and acyl CoA:cholesterol acyltransferase 2 expression (870%) were increased. In contrast, cholesterol synthesis was significantly reduced (70% decrease) with other lipoprotein particles. Furthermore, more cholesterol that entered the hepatocyte within LDL particles was secreted within VLDL particles (480%) compared with cholesterol from other sources.
CONCLUSIONS: Much of the cholesterol that enters the hepatocyte within LDL particles is shunted through the cell and resecreted within VLDL particles without reaching equilibrium with the regulatory pool.

Entities:  

Keywords:  3-hydroxy-3-methylglutaryl-coenzyme A; cholesterol; high-density lipoproteins; very–low-density lipoproteins

Mesh:

Substances:

Year:  2013        PMID: 23990208     DOI: 10.1161/ATVBAHA.113.301517

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  12 in total

1.  Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis.

Authors:  Qing Wu; Lulu Sun; Xiaomin Hu; Xuemei Wang; Feng Xu; Bo Chen; Xianyi Liang; Jialin Xia; Pengcheng Wang; Daisuke Aibara; Shaofei Zhang; Guangyi Zeng; Chuyu Yun; Yu Yan; Yicheng Zhu; Michael Bustin; Shuyang Zhang; Frank J Gonzalez; Changtao Jiang
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

2.  Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr-/- mice.

Authors:  Jinghua Bie; Jing Wang; Quan Yuan; Genta Kakiyama; Siddhartha S Ghosh; Shobha Ghosh
Journal:  J Lipid Res       Date:  2014-02-21       Impact factor: 5.922

Review 3.  Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering.

Authors:  Giuseppe Danilo Norata; Hagai Tavori; Angela Pirillo; Sergio Fazio; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2016-08-05       Impact factor: 10.787

Review 4.  Cholesterol and lipoprotein metabolism: Early Career Committee contribution.

Authors:  Hanrui Zhang; Ryan E Temel; Catherine Martel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09       Impact factor: 8.311

Review 5.  On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effects.

Authors:  Hagai Tavori; Shirya Rashid; Sergio Fazio
Journal:  Atherosclerosis       Date:  2014-12-17       Impact factor: 5.162

6.  PGC-1 coactivators in β-cells regulate lipid metabolism and are essential for insulin secretion coupled to fatty acids.

Authors:  Daniel Oropeza; Nathalie Jouvet; Khalil Bouyakdan; Gabrielle Perron; Lea-Jeanne Ringuette; Louis H Philipson; Robert S Kiss; Vincent Poitout; Thierry Alquier; Jennifer L Estall
Journal:  Mol Metab       Date:  2015-08-14       Impact factor: 7.422

7.  Shunts, channels and lipoprotein endosomal traffic: a new model of cholesterol homeostasis in the hepatocyte.

Authors:  Robert Scott Kiss; Allan Sniderman
Journal:  J Biomed Res       Date:  2017-01-19

Review 8.  PCSK9 and Atherosclerosis - Lipids and Beyond.

Authors:  Michael D Shapiro; Sergio Fazio
Journal:  J Atheroscler Thromb       Date:  2017-03-09       Impact factor: 4.928

9.  An in silico model of retinal cholesterol dynamics (RCD model): insights into the pathophysiology of dry AMD.

Authors:  Seyedeh Maryam Zekavat; James Lu; Cyrille Maugeais; Norman A Mazer
Journal:  J Lipid Res       Date:  2017-04-25       Impact factor: 5.922

10.  Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia.

Authors:  Karim Si-Tayeb; Salam Idriss; Benoite Champon; Amandine Caillaud; Matthieu Pichelin; Lucie Arnaud; Patricia Lemarchand; Cédric Le May; Kazem Zibara; Bertrand Cariou
Journal:  Dis Model Mech       Date:  2015-11-19       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.